Oxolife will present the first OXO-001 results at the European Congress of Human Reproduction (ESHRE)

OXOLIFE is thrilled to announce that on Monday, July the 8th, our CEO, Agnès Arbat Arbat, will be presenting the abstract “Efficacy results from the phase II randomized clinical trial: OXO-001 in infertile women undergoing egg donation IVF/ICSI” at the 40th Annual European Society of Human Reproduction and Embryology (ESHRE) Meeting, in Amsterdam . This presentation has been selected as one of the most exciting pieces of research to be showcased at the meeting. Session details: – Session Code: 1060 – Session Title: Session 06: Therapeutic Concepts in Implantation and Early Pregnancy – Time: 10:00 – 10:15 – Location: Park Foyer We are excited about the opportunity to connect face-to-face with experts in reproductive medicine from around the world.   Looking forward to seeing you in Amsterdam

The release as fetched from its publisher. oxolife.com ↗